Profit Investment Management adds Imprivata Inc (IMPR) to its portfolio

Imprivata Inc (IMPR) : Profit Investment Management added new position in Imprivata Inc during the most recent quarter end. The investment management firm now holds 131,972 shares of Imprivata Inc which is valued at $2,512,747 , the company said in a statement filed on Jul 22, 2016 with the SEC.Imprivata Inc makes up approximately 1.92% of Profit Investment Management’s portfolio.

Other Hedge Funds, Including , Magee Thomson Investment Partners reduced its stake in IMPR by selling 228 shares or 73.79% in the most recent quarter. The Hedge Fund company now holds 81 shares of IMPR which is valued at $1,542.

Imprivata Inc opened for trading at $19.05 and hit $19.16 on the upside on Friday, eventually ending the session at $19.12, with a gain of 0.37% or 0.07 points. The heightened volatility saw the trading volume jump to 3,00,629 shares. Company has a market cap of $484 M.

On the company’s financial health, Imprivata Inc reported $-0.21 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on May 3, 2016. Analyst had a consensus of $-0.31. The company had revenue of $31.52 million for the quarter, compared to analysts expectations of $29.28 million. The company’s revenue was up 22.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.24 EPS.

Many Wall Street Analysts have commented on Imprivata Inc. Imprivata Inc was Downgraded by Leerink Partners to ” Mkt Perform” on Jul 14, 2016. Imprivata Inc was Downgraded by Piper Jaffray to ” Neutral” on Jul 13, 2016.

Imprivata Inc. is a provider of healthcare information technology) IT security solutions. The Company’s solutions provide authentication management access to patient information and communications technologies to the healthcare industry. Its solutions include Imprivata OneSign Imprivata Cortext and Imprivata Confirm ID. Imprivata OneSign is a suite of authentication and access management products which consists of three offerings: authentication management enterprise single sign-on and workflow automation. Imprivata Cortext is a cloud-supported communications platform that provides healthcare organizations with texting and messaging services. Imprivata Confirm ID is a software product for electronic prescribing of controlled substances (EPCS).

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Imprivata Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Imprivata Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.